The total return over the past 12 months is -57.49% vs. +16.94% for the S&P 500. So far it's up -65.52% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (57.49%) | +156.72% | +67.94% | N/A | N/A | N/A |
| Total Return CAGR | (57.49%) | +156.72% | +67.94% | N/A | N/A | N/A |
| Revenue CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Regencell Bioscience Holdings Limited (RGC)
| Year | Start price | End price | RGC Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $21.00 | $7.24 | (65.52%) | +14.51% | (80.03%) |
| 2025 | $0.13 | $21.00 | +16053.85% | +17.72% | +16036.13% |
| 2024 | $0.28 | $0.13 | (52.95%) | +24.89% | (77.84%) |
| 2023 | $0.73 | $0.28 | (62.35%) | +26.19% | (88.54%) |
| 2022 | $0.84 | $0.73 | (12.43%) | (18.17%) | +5.74% |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
